The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan

Chemosphere

Volumn 84, Issue 1, 2011, Pages 17-24

  Chen, Jein Wen ^a   Chen, Hsiao Yen ^a   Li, Wan Fen ^a   Liou, Saou Hsing ^a   Chen, Chien Jen ^b,c   Wu, Jhuo Han ^a   Wang, Shu Li ^a,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Arsenic; Environmental epidemiology; Glomerular filtration rate; Renal dysfunction; Type 2 diabetes mellitus

Indexed keywords

ARSENIC; DISEASES;

BETA-2-MICROGLOBULIN; CARDIO-VASCULAR DISEASE; CIGARETTE SMOKING; ENVIRONMENTAL EPIDEMIOLOGY; ENVIRONMENTAL TOXICANTS; GLOMERULAR FILTRATION RATE; RENAL DYSFUNCTION; TYPE 2 DIABETES MELLITUS;

RISK PERCEPTION;

ARSENIC; BETA 2 MICROGLOBULIN; CADMIUM; CREATININE; LEAD; NICKEL;

AGE STRUCTURE; CANCER; CARDIOVASCULAR DISEASE; COMMUNITY STRUCTURE; CONCENTRATION (COMPOSITION); EPIDEMIOLOGY; FILTRATION; HEALTH RISK; HEAVY METAL; POPULATION STRUCTURE; RISK FACTOR; SEX RATIO; URINE;

ADULT; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; RISK FACTOR; TAIWAN; URINALYSIS;

TAIWAN;

EID: 79956087521     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2011.02.091     Document Type: Article

References (40)

1. ACGIH Threshold Limit Values for Chemicals and Physical Agents and Biological Exposure Indices for 1995-1996 1996, American Conference of Governmental Industrial Hygientists, Cincinnati, OH.
2. Arain M.B., Kazi T.G., Baig J.A., Jamali M.K., Afridi H.I., Shah A.Q., Jalbani N., Sarfraz R.A. Determination of arsenic levels in lake water, sediment, and foodstuff from selected area of Sindh, Pakistan: estimation of daily dietary intake. Food Chem. Toxicol. 2009, 47:242-248.
3. Arain M.B., Kazi T.G., Baig J.A., Jamali M.K., Afridi H.I., Jalbani N., Sarfraz R.A., Shah A.Q., Kandhro G.A. Respiratory effects in people exposed to arsenic via the drinking water and tobacco smoking in southern part of Pakistan. Sci. Total Environ. 2009, 407:5524-5530.
4. Baig J.A., Kazi T.G., Arain M.B., Afridi H.I., Kandhro G.A., Sarfraz R.A., Jamal M.K., Shah A.Q. Evaluation of arsenic and other physico-chemical parameters of surface and ground water of Jamshoro, Pakistan. J. Hazard. Mater. 2009, 166:662-669.
5. Buchet J.P., Heilier J.F., Bernard A., Lison D., Jin T., Wu X., Kong Q., Nordberg G. Urinary protein excretion in humans exposed to arsenic and cadmium. Int. Arch. Occup. Environ. Health 2003, 76:111-120.
6. Brima E.I., Haris P.I., Jenkins R.O., Polya D.A., Gault A.G., Harrington C.F. Understanding arsenic metabolism through a comparative study of arsenic levels in the urine, hair and fingernails of healthy volunteers from three unexposed ethnic groups in the United Kingdom. Toxicol. Appl. Pharmacol. 2006, 216:122-130.
7. Chang F.H., Wang H.J., Wang S.L., Wang Y.C., Hsieh D.P., Chang L.W., Ko Y.C. Survey of urinary nickel in residents of areas with a high density of electroplating factories. Chemosphere 2006, 65:1723-1730.
8. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25:53-60.
9. Chiou J.M., Wang S.L., Chen C.J., Deng C.R., Lin W., Tai T.Y. Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol. 2005, 34:936-943.
10. Chung J.S., Kalman D.A., Moore L.E., Kosnett M.J., Arroyo A.P., Beeris M., Mazumder D.N., Hernandez A.L., Smith A.H. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ. Health Perspect. 2002, 110:729-733.
11. Courtois E., Marques M., Barrientos A., Casado S., Lopez-Farre A. Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2. J. Am. Soc. Nephrol. 2003, 14:1464-1470.
12. de Burbure C., Buchet J.P., Leroyer A., Nisse C., Haguenoer J.M., Mutti A., Smerhovsky Z., Cikrt M., Trzcinka-Ochocka M., Razniewska G., Jakubowski M., Bernard A. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ. Health Perspect. 2006, 114:584-590.
13. Heck J.E., Nieves J.W., Chen Y., Parvez F., Brandt-Rauf P.W., Graziano J.H., Slavkovich V., Howe G.R., Ahsan H. Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangladesh. Environ. Health Perspect. 2009, 117:99-104.
14. Hong F., Jin T., Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals 2004, 17:573-580.
15. Hsueh Y.M., Chung C.J., Shiue H.S., Chen J.B., Chiang S.S., Yang M.H., Tai C.W., Su C.T. Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am. J. Kidney Dis. 2009, 54:859-870.
16. Hughes M.F. Biomarkers of exposure: a case study with inorganic arsenic. Environ. Health Perspect. 2006, 114:1790-1796.
17. IDBMOEA (International Development Bureau Ministry of Economic Affairs), 2002. Handbook of the Integrated Pollution Prevention Techniques for Metal Surface Treatment Industries - Electroplanting Industry. Industrial Development Bureau Ministry of Economic Affairs, Executive Yuan, Republic of China, Taipei.
18. Kazi T.G., Arain M.B., Baig J.A., Jamali M.K., Afridi H.I., Jalbani N., Sarfraz R.A., Shah A.Q., Niaz A. The correlation of arsenic levels in drinking water with the biological samples of skin disorders. Sci. Total Environ. 2009, 407:1010-1026.
19. Kristiansen J., Christensen J.M., Iversen B.S., Sabbioni E. Toxic trace element reference levels in blood and urine: influence of gender and lifestyle factors. Sci. Total Environ. 1997, 204:147-160.
20. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann. Intern. Med. 1999, 130:461-470.
21. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., De Zeeuw D., Hostetter T.H., Lameire N., Eknoyan G. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005, 67:2089-2100.
22. Li X., Pi J., Li B., Xu Y., Jin Y., Sun G. Urinary arsenic speciation and its correlation with 8-OHdG in Chinese residents exposed to arsenic through coal burning. Bull. Environ. Contam. Toxicol. 2008, 81:406-411.
23. Lindberg A.L., Ekstrom E.C., Nermell B., Rahman M., Lonnerdal B., Persson L.A., Vahter M. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ. Res. 2008, 106:110-120.
24. Montaser, A., 1998. Inductively Coupled Plasma Mass Spectrometry. George Washington University, Washington DC, USA, Wiley-VCH.
25. Navas-Acien A., Sharrett A.R., Silbergeld E.K., Schwartz B.S., Nachman K.E., Burke T.A., Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 2005, 162:1037-1049.
26. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008, 300:814-822.
27. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Burke T.A., Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 2006, 114:641-648.
28. Nordberg G.F., Jin T., Hong F., Zhang A., Buchet J.P., Bernard A. Biomarkers of cadmium and arsenic interactions. Toxicol. Appl. Pharmacol. 2005, 206:191-197.
29. Paschal D.C., Burt V., Caudill S.P., Gunter E.W., Pirkle J.L., Sampson E.J., Miller D.T., Jackson R.J. Exposure of the U.S. population aged 6 years and older to cadmium: 1988-1994. Arch. Environ. Contam. Toxicol. 2000, 38:377-383.
30. Seifert B., Becker K., Hoffmann K., Krause C., Schulz C. The german environmental survey 1990/1992 (GerES II): a representative population study. J. Expo. Anal. Environ. Epidemiol. 2000, 10:103-114.
31. Sinha M., Manna P., Sil P.C. Arjunolic acid attenuates arsenic-induced nephrotoxicity. Pathophysiol 2008, 15:147-156.
32. Smith A.H., Arroyo A.P., Mazumder D.N., Kosnett M.J., Hernandez A.L., Beeris M., Smith M.M., Moore L.E. Arsenic-induced skin lesions among Atacameno people in Northern Chile despite good nutrition and centuries of exposure. Environ. Health Perspect. 2000, 108:617-620.
33. Taiwan-EPA, 2003-2006. The Annual Report of Environmental Water Quality Monitoring: Groundwater Quality Section. Environmental Protection Administration, Executive Yuan, Taipei, Taiwan.
34. Tofail F., Vahter M., Hamadani J.D., Nermell B., Huda S.N., Yunus M., Rahman M., Grantham-McGregor S.M. Effect of arsenic exposure during pregnancy on infant development at 7 months in rural Matlab, Bangladesh. Environ. Health Perspect. 2009, 117:288-293.
35. Wang J.P., Wang S.L., Lin Q., Zhang L., Huang D., Ng J.C. Association of arsenic and kidney dysfunction in people with diabetes and validation of its effects in rats. Environ. Int. 2009, 35:507-511.
36. Wang S.L., Chang F.H., Liou S.H., Wang H.J., Li W.F., Hsieh D.P. Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ. Int. 2007, 33:805-811.
37. Wang S.L., Chiou J.M., Chen C.J., Tseng C.H., Chou W.L., Wang C.C., Wu T.N., Chang L.W. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ. Health Perspect. 2003, 111:155-159.
38. Wen C.P., Cheng T.Y., Tsai M.K., Chang Y.C., Chan H.T., Tsai S.P., Chiang P.H., Hsu C.C., Sung P.K., Hsu Y.H., Wen S.F. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008, 371:2173-2182.
39. White M.A., Sabbioni E. Trace element reference values in tissues from inhabitants of the European Union. X: a study of 13 elements in blood and urine of a United Kingdom population. Sci. Total Environ. 1998, 216:253-270.
40. Yoshida T., Yamauchi H., Fan Sun G. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol. Appl. Pharmacol. 2004, 198:243-252.